Device for rapid diagnostic tests to detect antigens with improved sensitivity
A rapid diagnostic testing device for testing of a biological sample is provided. The device comprises a channeled construct, at least one lateral flow unit, and a cassette housing. The channeled construct is configured to receive a biological sample to form at least partially purified biological sample. The lateral flow unit is at least partially disposed in the cassette housing. The lateral flow unit comprises: a sample receiving zone, a conjugate zone and a detection zone. The sample receiving zone is operatively coupled to the channeled construct for receiving the partially purified biological sample comprising at least one analyte. The conjugate zone comprising a conjugate particle to bind the analyte is disposed adjacent to the first side of the sample receiving zone. The detection zone is disposed adjacent to the second side of the sample receiving zone and comprises at least one binding agent for detecting the analyte.
1. A rapid diagnostic testing device for rapid diagnostic testing of a biological sample, comprising:
a channeled construct comprising a first surface and a second surface, wherein the first surface is configured to receive at least a portion of the biological sample and wherein channels of the channeled construct narrow from the first surface to the second surface such that the portion of the biological sample passes through the channels at the second surface to form at least partially purified biological sample;
at least one lateral flow unit operatively coupled to the channeled construct at the second surface, wherein the lateral flow unit comprises:
a sample receiving zone operatively coupled to the channeled construct for receiving the partially purified biological sample from the channeled construct, wherein the partially purified biological sample comprises at least one analyte, and wherein the sample receiving zone comprises a first side and a second side;
a conjugate zone disposed adjacent to the first side of the sample receiving zone, wherein the conjugate zone comprises a conjugate particle for binding with the analyte; and
a detection zone disposed adjacent to the second side of the sample receiving zone, wherein the detection zone comprises at least one binding agent for detecting the analyte by capturing the analyte; and
a cassette housing comprising a sample well and a plurality of rib structures extending from the cassette housing into an interior space formed by the cassette housing and proximate to the sample well such that a first rib structure of a first series of the plurality of rib structures extends from a top section of the cassette housing into the interior space a smaller distance relative to a second rib structure of the first series of the plurality of rib structures, wherein the first rib structure is closer to the sample well than the second rib structure, wherein the lateral flow unit is at least partially disposed in the interior space of the cassette housing, wherein a second series of the plurality of rib structures extends from a bottom section of the cassette housing, wherein the first rib structure contacts the first surface of the channeled construct, wherein the first surface is a top side of the channeled construct, and wherein the second rib structure contacts a top surface of the lateral flow unit.
2. The rapid diagnostic testing device of claim 1 , wherein the biological sample comprises blood, feces, sweat, saliva, mucous, milk, urine, semen, serum, plasma, sputum, tears, vaginal fluid, or tissue.
3. A rapid diagnostic testing device for rapid diagnostic testing of a blood sample, comprising:
a channeled construct comprising a first side configured to receive at least a portion of the blood sample for rapid separation of blood cells and plasma from the blood sample via a plurality of narrowing channels of the channeled construct, wherein the narrowing channels narrow towards a second side of the channeled construct;
at least one lateral flow unit operatively coupled to the channeled construct, wherein the lateral flow unit comprises:
a sample receiving zone operatively coupled to the channeled construct for receiving at least a portion of the plasma from the second side of the channeled construct, wherein the portion of the plasma comprises an analyte, and wherein the sample receiving zone comprises a first side and a second side;
a conjugate zone disposed adjacent to the first side of the sample receiving zone, wherein the conjugate zone comprises a conjugate particle for binding with the analyte; and
a detection zone disposed adjacent to the second side of the sample receiving zone, wherein the detection zone comprises at least one binding agent for detecting the analyte by capturing the analyte; and
a cassette housing comprising a sample well and a plurality of rib structures extending from the cassette housing into an interior space formed by the cassette housing such that a first rib structure of a first series of the plurality of rib structures positioned relatively closer to the sample well than a second rib structure of the first series of the plurality of rib structures is separated from the lateral flow unit by the channeled construct, wherein the first rib structure directly contacts the first side of the channeled construct, wherein the first side is a top side of the channeled construct, wherein the second rib structure positioned relatively farther from the sample well directly contacts a top surface of the lateral flow unit, and wherein the lateral flow unit is at least partially disposed in the interior space of the cassette housing.
4. The rapid diagnostic testing device of claim 3 , wherein the channeled construct is disposed vertically relative to the at least one lateral flow unit.
5. The rapid diagnostic testing device of claim 3 , wherein the detection zone comprises a test region and wherein the binding agent is deposited thereon.
6. The rapid diagnostic testing device of claim 3 , wherein the binding agent is a primary antibody that binds to the analyte, a labeled primary antibody that binds to the analyte, a secondary antibody that binds to the analyte, or a labeled secondary antibody that binds to the analyte.
7. The rapid diagnostic testing device of claim 3 , wherein the conjugate particle comprises a secondary antibody that binds to the analyte.
8. The rapid diagnostic testing device of claim 3 , wherein the analyte is selected from a malarial biomarker, an influenza biomarker, a cardiac biomarker, a tumor biomarker, or combinations thereof.
9. The rapid diagnostic testing device of claim 8 , wherein the analyte is a malarial biomarker histidine rich protein II (HRP 2).
10. The rapid diagnostic testing device of claim 8 , wherein the analyte is a cardiac biomarker CK-MB.
11. The rapid diagnostic testing device of claim 3 , wherein the sample receiving zone and the conjugate zone comprises a common substrate.
12. The rapid diagnostic testing device of claim 11 , wherein the conjugate particle of the conjugate zone is present at one end of the common substrate and the sample receiving zone is present at another end of the common substrate.
13. The rapid diagnostic testing device of claim 3 , wherein the sample receiving zone, the conjugate zone, and the detection zone comprises a common substrate.
14. The rapid diagnostic testing device of claim 3 , wherein the lateral flow unit comprises glass fiber, nitrocellulose membrane, quartz, or combinations thereof.
15. The rapid diagnostic testing device of claim 3 , wherein the detection zone is present on a nitrocellulose membrane disposed on a separate layer from the sample receiving zone.
16. The rapid diagnostic testing device of claim 3 , wherein the lateral flow unit further comprises a buffer reservoir disposed adjacent to the conjugate zone.
17. The rapid diagnostic testing device of claim 16 , wherein the buffer reservoir comprises a non-lytic buffer, a buffer with a surfactant concentration of less than about 0.01 mM, or a combination thereof.
18. The rapid diagnostic testing device of claim 3 , wherein a volume of the blood sample is in a range from about 25 μL to about 200 μL.
19. The rapid diagnostic testing device of claim 3 , wherein the channeled construct comprises a size exclusion separation element that is a porous membrane having a first surface and a second surface, wherein the first surface of the porous membrane is substantially planar with a raised edge surrounding the first surface of the porous membrane.
20. The rapid diagnostic testing device of claim 19 , wherein at least a portion of the second surface of the porous membrane of the channeled construct is in contact with the sample receiving zone of the lateral flow unit.
21. The rapid diagnostic testing device of claim 3 , wherein the sample well of the cassette housing comprises at least one wall, a first aperture, and a second aperture, and wherein the wall along with the first and second apertures forms a channel, and wherein the second aperture includes a flange.
22. The rapid diagnostic testing device of claim 21 , wherein the channeled construct is disposed on the lateral flow unit to form a gap between the second aperture and the channeled construct, such that the flange of the second aperture is positioned to contact the channeled construct.